German startup TimeTeller launches saliva test for circadian medicine

Berlin-based TimeTeller has launched a saliva test kit that lets consumers map their circadian rhythm at home, TechCrunch reported. The startup aims to use the data to personalize drug timing and reduce side effects, starting with cancer treatments.

The test arrives as regulators and pharma companies show growing interest in how drug efficacy varies by time of day. Some recent guidance has encouraged sponsors to collect circadian data in early-phase trials, though most studies still rely on wrist-worn actigraphy or self-reported sleep logs. TimeTeller’s direct molecular readout could provide a cheaper, more precise alternative.

When we covered Alberta’s regenerative medicine hub last month, the focus was on accelerating cell therapies to market. TimeTeller’s approach flips the script: instead of engineering new cells, it tunes existing treatments to the patient’s internal clock. That distinction may appeal to payers wary of high-cost biologics.

The startup has not disclosed funding or clinical partnerships, leaving open whether it will license its assay to pharma or build a consumer-facing subscription. Either path would require clearing regulatory hurdles; saliva-based circadian biomarkers are still in development. For now, the product is positioned as a wellness tool, but its long-term value lies in the clinical data it generates.

Sources: techcrunch.com